Acomplia: BMI Limits
"Acomplia, however, appears to be more effective because of its wider effect through the body. It has been tested on 6600 people in nine countries, more than 1000 of them in Britain.
The drug trials not only promoted weight loss in at least a quarter of those taking it, but also produced lowering of cholesterol and blood fat levels far greater than would be achieved by diet alone. It is these benefits that are supporting hopes that the drug could cut the taxpayer bill for treating obesity.
Acomplia's initial UK licence will limit its use to people who have a body mass index (BMI) of at least 30. Someone is considered to be obese if they have a BMI of 30 or higher.
But the licence will also allow it to be prescribed for patients with slightly lower BMIs, of 27, if these patients also have other risk factors such as diabetes and high blood pressure.
BMI is a formula based on weight-to-height ratio, and no one weighing under at least 160kg will initially be eligible. "
acomplia
rimonabant
accomplia
0 Comments:
Post a Comment
<< Home